Patents by Inventor Samuel L. Stanley, Jr.

Samuel L. Stanley, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amebic glycoconjugate and monoclonal antibody
    Patent number: 5275935
    Abstract: An amebic glycoconjugate is disclosed that is recognized by an Entamoeba histolytica specific monoclonal antibody The glycoconjugate is isolated from the lysates of E. histolytica trophozoites, it is phosphorylated, lipid-containing, glycosylated, migrates as a polydisperse band on SDS-PAGE between about 65-200 kDa and is specifically recognized by monoclonal antibody CC 8.6, ATCC HB 11104.
    Type: Grant
    Filed: September 10, 1992
    Date of Patent: January 4, 1994
    Assignee: Washington University
    Inventors: Samuel L. Stanley, Jr., Ellen Li
  • Entamoeba histolytica diagnostic assay
    Patent number: 5206142
    Abstract: An Entamoeba histolytica specific cDNA clone which encodes an antigenic surface membrane protein possessing multiple tandem repeats and expression in E. coli is disclosed. This surface membrane protein is useful in a diagnostic assay for amebiosis.
    Type: Grant
    Filed: April 27, 1992
    Date of Patent: April 27, 1993
    Assignee: Washington University
    Inventors: Samuel L. Stanley, Jr., Ellen Li
  • Entamoeba histolytical immunogenic protein and cDNA clone
    Patent number: 5130417
    Abstract: An Entamoeba histolytica specific cDNA clone which encodes an antigenic surface membrane protein possessing multiple tandem repeats and expression in E. coli is disclosed.
    Type: Grant
    Filed: April 30, 1990
    Date of Patent: July 14, 1992
    Assignee: Washington University
    Inventors: Samuel L. Stanley, Jr., Ellen Li